Chaluvadi MR[au] - Search Results

Year	Number of Results
1999	1
2000	1
2002	3
2004	1
2008	4
2009	3
2023	0

1

Paracetamol metabolism in Indian population.

Pabba SK, Bolla S, Kandhagatla R, Chaluvadi MR, Krishna DR. Pabba SK, et al. Among authors: chaluvadi mr. Arzneimittelforschung. 2002;52(10):769-72. doi: 10.1055/s-0031-1299964. Arzneimittelforschung. 2002. PMID: 12442640 Clinical Trial.

2

Hepatic flavin-containing monooxygenase gene regulation in different mouse inflammation models.

Zhang J, Chaluvadi MR, Reddy R, Motika MS, Richardson TA, Cashman JR, Morgan ET. Zhang J, et al. Among authors: chaluvadi mr. Drug Metab Dispos. 2009 Mar;37(3):462-8. doi: 10.1124/dmd.108.025338. Epub 2008 Dec 16. Drug Metab Dispos. 2009. PMID: 19088265 Free PMC article.

3

Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer.

Morgan ET, Goralski KB, Piquette-Miller M, Renton KW, Robertson GR, Chaluvadi MR, Charles KA, Clarke SJ, Kacevska M, Liddle C, Richardson TA, Sharma R, Sinal CJ. Morgan ET, et al. Among authors: chaluvadi mr. Drug Metab Dispos. 2008 Feb;36(2):205-16. doi: 10.1124/dmd.107.018747. Drug Metab Dispos. 2008. PMID: 18218849

4

Regulation of hepatic cytochrome P450 expression in mice with intestinal or systemic infections of citrobacter rodentium.

Chaluvadi MR, Kinloch RD, Nyagode BA, Richardson TA, Raynor MJ, Sherman M, Antonovic L, Strobel HW, Dillehay DL, Morgan ET. Chaluvadi MR, et al. Drug Metab Dispos. 2009 Feb;37(2):366-74. doi: 10.1124/dmd.108.024240. Epub 2008 Oct 29. Drug Metab Dispos. 2009. PMID: 18971315 Free PMC article.

5

TLR4-dependent and -independent regulation of hepatic cytochrome P450 in mice with chemically induced inflammatory bowel disease.

Chaluvadi MR, Nyagode BA, Kinloch RD, Morgan ET. Chaluvadi MR, et al. Biochem Pharmacol. 2009 Feb 1;77(3):464-71. doi: 10.1016/j.bcp.2008.10.029. Epub 2008 Nov 6. Biochem Pharmacol. 2009. PMID: 19027721 Free PMC article.

6

HPLC method for the determination of rosiglitazone in human plasma and its application in a clinical pharmacokinetic study.

Mamidi RN, Chaluvadi MR, Benjamin B, Ramesh M, Katneni K, Babu AP, Bhanduri J, Rao NM, Rajagopalan R. Mamidi RN, et al. Among authors: chaluvadi mr. Arzneimittelforschung. 2002;52(7):560-4. doi: 10.1055/s-0031-1299930. Arzneimittelforschung. 2002. PMID: 12189780 Clinical Trial.

7

Intravenous pharmacokinetics, oral bioavailability and dose proportionality of ragaglitazar, a novel PPAR-dual activator in rats.

Jagannath K, Chaluvadi MR, Mullangi R, Mamidi NV, Srinivas NR. Jagannath K, et al. Among authors: chaluvadi mr. Biopharm Drug Dispos. 2004 Oct;25(7):323-8. doi: 10.1002/bdd.413. Biopharm Drug Dispos. 2004. PMID: 15386480

8

Polymorphism of dextromethorphan oxidation in South Indian subjects.

Mamidi RN, Satyavageeswaran S, Vakkalanka SV, Chaluvadi MR, Katneni K, Brahmadevara N, Damodarram G, Subramaniam S. Mamidi RN, et al. Among authors: chaluvadi mr. Clin Pharmacol Ther. 1999 Aug;66(2):193-200. doi: 10.1053/cp.1999.v66.99989. Clin Pharmacol Ther. 1999. PMID: 10460073

9

Validated HPLC method for the determination of tinidazole in human serum and its application in a clinical pharmacokinetic study.

Rajnarayana K, Chaluvadi MR, Alapati VR, Mada SR, Jayasagar G, Krishna DR. Rajnarayana K, et al. Among authors: chaluvadi mr. Pharmazie. 2002 Aug;57(8):535-7. Pharmazie. 2002. PMID: 12227192 Clinical Trial.

10

Validated HPLC method for determination of PAT-5A, an insulin sensitizing agent, in rat plasma.

Kumar VV, Katneni K, Chaluvadi MR, Shreeram S, Gangadhar S, Nataraj B, Kishore PH, Bhushan V, Subramaniam S. Kumar VV, et al. Among authors: chaluvadi mr. J Pharm Biomed Anal. 2000 Mar;22(2):251-5. doi: 10.1016/s0731-7085(99)00262-9. J Pharm Biomed Anal. 2000. PMID: 10719907

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results